维普期刊资源整合服务平台（V6.5）

203篇 您的检索式：作者名="Zejnullahu"

选中清除导出查看参考文献查看引证文献引用追踪共11页首页上一页第1页下一页末页 /11 跳转

	题名	作者	年代	出处	被引量
1	MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling显示文摘	ENGELMAN J A ZEJNULLAHU K MITSUDOMI T	2007	Science2007，316，5827：	1
2	MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling显示文摘	Engelman JA Zejnullahu K Mitsudomi T etal	2007	Science2007，316，5827：	1
3	MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling显示文摘	Engelman JA Zejnullahu K Mitsudomi T		0，，5827：	1
4	EML4-ALK fusiongene andefficacy of an ALK kinase inhibitor in lung cancer显示文摘	Koivunen JP Mermel C Zejnullahu K	2008	Clin Cancer Res2008，14，：	1
5	MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling显示文摘	Engelman JA Zejnullahu K Mitsudomi T	2007	Science2007，316，5827：	1
6	MET amplification leads to gefitinib resistance in lung cancer by activating ErbB3 signaling显示文摘	Engelman JA Zejnullahu K Mitsudomi T	2007	Science2007，316，5827：	1
7	Preexistence and clonal selection of MET amplification in EGFR mutant NSCLC显示文摘	Turke AB Zejnullahu K Wu YL		0，，：	1
8	MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling显示文摘	Engelman JA Zejnullahu K Mitsudomi T	2007	Science2007，316，5827：	1
9	MET am- plification leads to gefitinib resistance in lung cancer by ac- tivating ERBB3 signaling显示文摘	Engelman JA Zejnullahu K Mitsudomi T	2007	Science2007，316，5827：	1
10	MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling显示文摘	Engelman JA Zejnullahu K Mitsudomi T	2007	Science2007，316，5827：	1
11	Allelic dilution obscures detection of a biologically significant resistance mutation in EGFR-amplified lung cancer显示文摘	Engelman JA Mukohara T Zejnullahu K	2006	J Clin Invest2006，116，10：	1
12	Preexistence and Clonal Selection of MET Amplification in EGFR Mutant NSCLC 显示文摘	Turke AB Zejnullahu K Wu YL	2010	Cancer Cell2010，17，1：	1
13	EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer 显示文摘	Koivunen JP Mermel C Zejnullahu K	2008	Clin Cancer Res2008，14，13：	1
14	MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling显示文摘	ENGELMAN J A ZEJNULLAHU K MITSUDOMI T	2007	Science2007，316，5827：	1
15	MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling显示文摘	ENGELMAN J A ZEJNULLAHU K MITSUDOMI T	2007	Science2007，316，5827：	1
16	EML4-ALK fusiongene and efficacy of an ALK kinase inhibitor in lung cancer显示文摘	Koivunen JP Mermel C Zejnullahu K	2008	Clin Cancer Res2008，14，13：	1
17	EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer显示文摘	Koivunen JP Mermel C Zejnullahu K	2008	Clin Cancer Res2008，14，13：	1
18	MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling 显示文摘	Engelman JA Zejnullahu K Mitsudomi T	2007	Science2007，86，5827：	1
19	MET amplifica-tion leads to gefitinib resistance in lung cancer by activatingERBB3 signaling显示文摘	Engelman JA Zejnullahu K Mitsudomi T	2007	Science2007，316，5827：	1
20	EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer显示文摘	Koivunen J P Mermel C Zejnullahu K	2008	Clin Cancer Res2008，14，13：	1

返回顶部每页显示：

共11页首页上一页第1页下一页末页 /11 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示